ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BNTX BioNTech SE

93.88
0.31 (0.33%)
Feb 24 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 493,336
Bid Price 93.86
Ask Price 94.30
News -
Company Name Stock Ticker Symbol Market Type
BioNTech SE BNTX NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.31 0.33% 93.88 00:00:10
Open Price Low Price High Price Close Price Prev Close
94.26 92.51 94.88 93.97 93.57
Trades Volume VWAP Dollar Volume Avg Volume
9,128 493,336  93.95  46,350,630 -
Last Trade Time Type Quantity Stock Price Currency
19:19:07 formt 100  93.88 USD

BioNTech (BNTX) Options Flow Summary

Overall Flow

Bearish

Net Premium

-33k

Calls / Puts

0.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

BioNTech SE Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 240.99M - 17.31B 9.43B - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News BioNTech

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BNTX Message Board. Create One! See More Posts on BNTX Message Board See More Message Board Posts

BNTX Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

BioNTech SE is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.

Your Recent History

Delayed Upgrade Clock